TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23238142

Group type: EXPERIMENTAL
Intervention: Three cycles of AC regimen followed by three cycles of Paclitaxel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Six cycles of AC regimen
Number of subjects: 50
Study: 20850091

Group type: EXPERIMENTAL
Intervention: Local intracoronary delivery of abciximab through a dedicated perfusion catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intracoronary infusion of abciximab through the guiding catheter
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Local intracoronary delivery of abciximab
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intracoronary infusion of abciximab
Number of subjects: 50
Study: 17620527

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 6315

Group type: COMPARATOR
Intervention: Fibrinolysis
Number of subjects: 6315
Study: 15832331

Group type: EXPERIMENTAL
Intervention: Real magnetic field (MF) exposure
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham magnetic field (MF) exposure
Number of subjects: 24

Group type: COMPARATOR
Intervention: Real and sham EMF exposure
Number of subjects: 24
Study: 12577328

Group type: EXPERIMENTAL
Intervention: Combined HACE and Chinese herbal medicine (Gan'ai No. I and No. II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: HACE alone
Number of subjects: 60
Study: 9243959

Group type: EXPERIMENTAL
Intervention: Random feedback (success)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Random feedback (failure)
Number of subjects: 60
Study: 8500518

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (untreated subjects)
Number of subjects: 4
Study: 3034690

Group type: EXPERIMENTAL
Intervention: Topical application of LTB4
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Topical application of 12-HETE
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control lesions (not specified treatment)
Number of subjects: 9
Study: 2543582

Group type: EXPERIMENTAL
Intervention: Natural or synthetic retinoids (RA, acitretin, isotretinoin, Ro137410, retinol) applied daily for 4 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical dithranol treatment, UVB irradiation, or scotch tape stripping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical diflucortolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ro150778 (no affinity and no reported transformation)
Number of subjects: 0
Study: 31404053

Group type: EXPERIMENTAL
Intervention: Robot-assisted technique (TINAVI)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Robot-assisted technique (Renaissance)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Robot-assisted techniques
Number of subjects: 696

Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 696
Study: 31595867

Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control households (no ITNs)
Number of subjects: 0
Study: 28617848

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 9
Study: 27337853

Group type: EXPERIMENTAL
Intervention: Postpartum IUD insertion
Number of subjects: 28
Study: 23983239

Group type: EXPERIMENTAL
Intervention: Low PTEN expression
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: PTEN and IGF-IR expression models
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Normal level of IGF-IR expression
Number of subjects: 805
Study: 21348213

Group type: COMPARATOR
Intervention: 5 mg of ephedrine intravenously (EPHE‐5)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 10 mg of ephedrine intravenously (EPHE‐10)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 500 mL of HES 130/0.4 in rapid infusion over 15 minutes
Number of subjects: 96
Study: 19130635

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture treatment group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nontreatment group (control)
Number of subjects: 100
Study: 16816926

Group type: EXPERIMENTAL
Intervention: Ospemifene 30 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ospemifene 90 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Raloxifene 60 mg
Number of subjects: 118
Study: 15273435

Group type: EXPERIMENTAL
Intervention: Early carotid endarterectomy (CEA) within 24 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed carotid endarterectomy (CEA) at 8 weeks
Number of subjects: 40
Study: 11515884

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g bolus before skin incision, followed by continuous infusion of 400 mg/hr during surgery)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 40
Study: 9248987

Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gastric banding
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study: 8498877

Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: New psychopharmacologic treatments
Number of subjects: 54
Study: 3101804

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 30945493

Group type: EXPERIMENTAL
Intervention: Acupuncture group (deep needling of Lianquan (CV23) and Yifeng (TE17), conventional acupuncture of other acupoints, electroacupuncture stimulation)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (conventional swallowing rehabilitation training)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 28244407

Group type: EXPERIMENTAL
Intervention: Hypofractionated IMRT (HIMRT) - 70.2 Gy in 26 fractions
Number of subjects: 303

Group type: COMPARATOR
Intervention: Conventional IMRT (CIMRT) - 76 Gy in 38 fractions
Number of subjects: 303
Study: 25680826

Group type: EXPERIMENTAL
Intervention: SFI + EGDT
Number of subjects: 45

Group type: COMPARATOR
Intervention: EGDT
Number of subjects: 45
Study: 23590271

Group type: EXPERIMENTAL
Intervention: Dead space (DS) loading of 0.6 L during exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unloaded control
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dead space (DS) loading of 0.6 L at 60 W
Number of subjects: 40
Study: 21218306

Group type: EXPERIMENTAL
Intervention: Individual motivational interviewing
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Group motivational interviewing
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Nurse‐led hepatitis health promotion
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 256
Study: 19221371

Group type: EXPERIMENTAL
Intervention: Drug facts box in symptom drug box trial
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (actual drug ads) in symptom drug box trial
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Drug facts box in prevention drug box trial
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (actual drug ads) in prevention drug box trial
Number of subjects: 450
Study: 17143125

Group type: EXPERIMENTAL
Intervention: NRT + C-MIS
Number of subjects: 385

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 385
Study: 12547988

Group type: EXPERIMENTAL
Intervention: Japan's contribution to cardiovascular disease research
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized Controlled Trials (RCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Case-Control/Cohort Studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Case Reports
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall contribution
Number of subjects: 0
Study: 11320598

Group type: EXPERIMENTAL
Intervention: Multicenter clinical trials
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Careful planning and monitoring
Number of subjects: 20
Study: 9426082

Group type: COMPARATOR
Intervention: Conventional jet nebulizer (Acorn)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional jet nebulizer with storage chamber (Mizer)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Venturi nebulizer (Ventstream)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Venturi nebulizer (Pari LC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both Venturi nebulizers
Number of subjects: 18
Study: 8513906

Group type: EXPERIMENTAL
Intervention: Collagen impregnated Dacron (Meadox Hemashield)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Albumen coated Dacron (USCI)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard knitted Dacron (Meadox Microvel, UCSI Vasculour II) preclotted with patient's own blood
Number of subjects: 36
Study: 2960925

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 100
Study: 31039797

Group type: EXPERIMENTAL
Intervention: Multi-family therapy (MFT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Systemic single-family therapy (SFT)
Number of subjects: 150
Study: 27678469

Group type: EXPERIMENTAL
Intervention: LDU‐LV
Number of subjects: 147

Group type: COMPARATOR
Intervention: LV
Number of subjects: 147
Study: 27022659

Group type: EXPERIMENTAL
Intervention: Anoro Ellipta (vilanterol and umeclidinium bromide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22142537

Group type: EXPERIMENTAL
Intervention: SunshowerMedical home UV device, used daily for 6 minutes over 6 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Hospital UVB treatment (Waldmann 85/UV21 lamps), twice a week for 6 weeks
Number of subjects: 29
Study: 21456039

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg/day plus modafinil 400 mg/day (200 mg bid)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Fluoxetine 40 mg/day plus placebo
Number of subjects: 46
Study: 17692108

Group type: EXPERIMENTAL
Intervention: Bicalutamide
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 43

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 43
Study: 16522393

Group type: EXPERIMENTAL
Intervention: Antibiotics (metronidazole 250 mg and erythromycin 250 mg tid orally for 7 days prenatally, metronidazole 250 mg and ampicillin 500 mg q 4 hours during labor)
Number of subjects: 2433

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 2433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2433

Group type: EXPERIMENTAL
Intervention: Antibiotics and Placebo
Number of subjects: 2433

Group type: EXPERIMENTAL
Intervention: HIV-infected women
Number of subjects: 2433
Study: 14514590

Group type: EXPERIMENTAL
Intervention: Nonremovable fiberglass cast boot (n = 42)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Off‐loading shoes (n = 51)
Number of subjects: 93
Study: 11126185

Group type: EXPERIMENTAL
Intervention: ECT plus rTMS (one UL ECT on Day 1 and rTMS on the following 4 days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: ECT only (non-dominant unilateral ECT, 3 times per week for 2 weeks)
Number of subjects: 22
Study: 8982890

Group type: EXPERIMENTAL
Intervention: Caudal block with 1.5 ml/kg of 0.2% bupivacaine (Group I)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Local infiltration of the surgical site with up to 1.2 ml/kg of 0.25% bupivacaine (Group 2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Caudal epidural block (Group I)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Local infiltration (Group 2)
Number of subjects: 16
Study: 1735480

Group type: EXPERIMENTAL
Intervention: Ovarian electrocautery + hMG
Number of subjects: 33

Group type: COMPARATOR
Intervention: LH-RH-a + hMG
Number of subjects: 33
Study: 6099055

Group type: EXPERIMENTAL
Intervention: Etomidate (0.3 mg/kg body wt.)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Thiopentone (4 mg/kg body wt.)
Number of subjects: 18
Study: 31697244

Group type: EXPERIMENTAL
Intervention: Well-being mobile app (8-week program, 4 classes per week, 15-min guided practice)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Active control app (4 assessments per week, 20 min self-observation)
Number of subjects: 490
Study: 30286755

Group type: EXPERIMENTAL
Intervention: IVR behavior support
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Human-delivered behavior support
Number of subjects: 301

Group type: COMPARATOR
Intervention: IVR control condition
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: SIPsmartER participants
Number of subjects: 301
Study: 24882503

Group type: EXPERIMENTAL
Intervention: Child ADHD/ODD-like behavior
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Elevated adult ADHD symptoms
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Child ADHD/ODD-like behavior and adult ADHD symptoms interaction
Number of subjects: 90

Group type: COMPARATOR
Intervention: Typical behavior (control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Observer-coded parenting and interparental communication
Number of subjects: 90
Study: 23365258

Group type: EXPERIMENTAL
Intervention: Force channel to constrain hand motion to a straight line
Number of subjects: 0

Group type: COMPARATOR
Intervention: No force channel
Number of subjects: 0
Study: 21030232

Group type: EXPERIMENTAL
Intervention: Stage II COPD
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Stage III COPD
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Stage IV COPD
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Exacerbation of respiratory symptoms
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Comorbid conditions
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Hospital COPD patients
Number of subjects: 213

Group type: COMPARATOR
Intervention: Population-based controls
Number of subjects: 213
Study: 19104775

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 20 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 40 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 60 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 33
Study: 16843480

Group type: EXPERIMENTAL
Intervention: Warming up (muscle warm-up protocol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 30
Study: 15281672

Group type: EXPERIMENTAL
Intervention: New pre-employment medical assessment system
Number of subjects: 352

Group type: COMPARATOR
Intervention: Old pre-employment medical assessment system
Number of subjects: 352
Study: 11495140

Group type: EXPERIMENTAL
Intervention: B‐HA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: NC‐HA
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison between B‐HA and NC‐HA
Number of subjects: 10
Study: 9923060

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily
Number of subjects: 370

Group type: COMPARATOR
Intervention: Clarithromycin 250 mg twice daily
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 370

Group type: COMPARATOR
Intervention: Clarithromycin
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil and Clarithromycin
Number of subjects: 370
Study: 9192156

Group type: EXPERIMENTAL
Intervention: Delton sealant
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Duraphat varnish
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 344

Group type: COMPARATOR
Intervention: Sealant vs Control
Number of subjects: 344

Group type: COMPARATOR
Intervention: Varnish vs Control
Number of subjects: 344

Group type: COMPARATOR
Intervention: Sealant vs Varnish
Number of subjects: 344
Study: 2044903

Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole (40 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral omeprazole (80 mg)
Number of subjects: 9
Study: 6266642

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with MER (methanol-extracted residue of bacillus Calmette-Guerin)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Combination chemotherapy without MER
Number of subjects: 103
Study: 30835827

Group type: EXPERIMENTAL
Intervention: One-stage IBBR with acellular dermal matrix (ADM)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Two-stage IBBR
Number of subjects: 121
Study: 27581586

Group type: EXPERIMENTAL
Intervention: Mechanical dilatation of the cervix during cesarean section
Number of subjects: 447

Group type: COMPARATOR
Intervention: No dilatation of the cervix during cesarean section
Number of subjects: 447
Study: 26952289

Group type: EXPERIMENTAL
Intervention: Higher urinary sulfate concentration
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Urinary sulfate concentration
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Follow-up for 12 months
Number of subjects: 1004
Study: 25124692

Group type: EXPERIMENTAL
Intervention: Supported Employment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional Vocational Rehabilitation
Number of subjects: 100
Study: 22940119

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone once daily from the day after insemination until 12 weeks of pregnancy or for 14 days in non-pregnant women
Number of subjects: 290

Group type: COMPARATOR
Intervention: No progesterone (unsupported cycles)
Number of subjects: 290
Study: 20590478

Group type: EXPERIMENTAL
Intervention: SJW 300 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SJW 600 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 17566826

Group type: EXPERIMENTAL
Intervention: Rectal contrast CT
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Dual-contrast CT
Number of subjects: 232

Group type: COMPARATOR
Intervention: Noncontrast enhanced CT
Number of subjects: 232
Study: 16252285

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Time after feeding
Number of subjects: 20
Study: 12394765

Group type: EXPERIMENTAL
Intervention: Standard dose intravesical BCG (120 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low dose intravesical BCG (40 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both doses of intravesical BCG
Number of subjects: 26
Study: 9783492

Group type: EXPERIMENTAL
Intervention: Perindopril (ACE inhibitor) alone or in combination with indapamide (diuretic)
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study: 8197045

Group type: EXPERIMENTAL
Intervention: Erythromycin 1.0 g/day for 10 days
Number of subjects: 252
Study: 2853457

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (16 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 50
Study: 29671166

Group type: EXPERIMENTAL
Intervention: Four construct intervention
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Single construct interventions
Number of subjects: 317
Study: 27546740

Group type: EXPERIMENTAL
Intervention: Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE)
Number of subjects: 71
Study: 25919011

Group type: EXPERIMENTAL
Intervention: Pain Exposure Physical Therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 56
Study: 22045098

Group type: EXPERIMENTAL
Intervention: Low-GDP PDF
Number of subjects: 125

Group type: COMPARATOR
Intervention: Conventional PDF
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study: 20420642

Group type: EXPERIMENTAL
Intervention: Milrinone (n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal saline (control group, n = 19)
Number of subjects: 38
Study: 18783988

Group type: EXPERIMENTAL
Intervention: HPV testing with p16-INK4A triage
Number of subjects: 24661

Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 24661

Group type: EXPERIMENTAL
Intervention: HPV testing with p16-INK4A triage (5% or more stained cells deemed positive)
Number of subjects: 24661
Study: 15879836

Group type: EXPERIMENTAL
Intervention: 10 mg vardenafil
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: 20 mg vardenafil
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 12507208

Group type: EXPERIMENTAL
Intervention: 5FU-based regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined chemotherapy plus radiation therapy
Number of subjects: 0
Study: 10507814

Group type: EXPERIMENTAL
Intervention: Icodextrin (Ico)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Glucose (Glu)
Number of subjects: 38
Study: 10457792

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily for 2 weeks, then increased to 10 mg once daily if diastolic blood pressure did not fall below 90 mmHg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 20
Study: 1388003

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 6437954

Group type: EXPERIMENTAL
Intervention: Metergoline
Number of subjects: 8
Study: 30284065

Group type: EXPERIMENTAL
Intervention: Egg ovalbumin-derived protein hydrolysate (3 g/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (3 g/day)
Number of subjects: 75
Study: 28646591

Group type: EXPERIMENTAL
Intervention: Monochloroacetic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of cryotherapy and salicylic acid
Number of subjects: 0
Study: 27871759

Group type: COMPARATOR
Intervention: Basiliximab induction with low-dose tacrolimus, mycophenolate mofetil, and steroid maintenance therapy (arm A)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Rapid corticosteroid withdrawal on day 8 after basiliximab induction (arm B)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Rapid corticosteroid withdrawal on day 8 after rabbit ATG (arm C)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Control arm A (basiliximab induction)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Comparison of BPAR rates between arms
Number of subjects: 615

Group type: COMPARATOR
Intervention: Comparison of post-transplantation diabetes incidence
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Patient survival and censored graft survival
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Safety parameters (infections, malignancies)
Number of subjects: 615